Cite
HARVARD Citation
Pankov, D. et al. (n.d.). 96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo. Journal for immunotherapy of cancer. pp. A60-A61. [Online].